The majority of analysts have a bullish outlook on Boston Scientific, with several raising their price targets, indicating positive sentiment. The increase in the average price target suggests expectations of stock price appreciation. However, the company's profitability metrics are below industry averages, which could pose challenges. Overall, the positive analyst sentiment and raised price targets are likely to have a short-term positive impact on the stock price.